Advertisement
Screener

SUCAMPO PHARMACEUTICALS, INC. Net Income

SUCAMPO PHARMACEUTICALS, INC. Net Income

SUCAMPO PHARMACEUTICALS, INC. reported Net Income of $10.37 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-01.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2017-11-01

  • SUCAMPO PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2017-09-30 was $10.37M, a 28.11% increase year-over-year.
  • SUCAMPO PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2017-06-30 was -$181.17M.
  • SUCAMPO PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2017-03-31 was $4.62M.
  • SUCAMPO PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2016-12-31 was $15.28M, a 50.56% increase year-over-year.
  • SUCAMPO PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2016 was $18.49M, a 44.60% decline from fiscal 2015.
  • SUCAMPO PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2015 was $33.37M, a 154.20% increase from fiscal 2014.
  • SUCAMPO PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2014 was $13.13M, a 87.14% increase from fiscal 2013.
  • SUCAMPO PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2013 was $7.01M, a 38.61% increase from fiscal 2012.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 6 month as first filedNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 9 month as first filedNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2017-09-30$10.37M
10-Q · filed 2017-11-01
-$170.80M
derived: sum of 2 quarters · filed 2017-11-01
-$166.18M
10-Q · filed 2017-11-01
-$150.89M
derived: sum of 4 quarters · filed 2017-11-01
2017-06-30-$181.17M
10-Q · filed 2017-08-02
-$176.54M
10-Q · filed 2017-08-02
-$161.26M
derived: sum of 3 quarters · filed 2017-08-02
-$153.17M
derived: sum of 4 quarters · filed 2017-11-01
2017-03-31$4.62M
10-Q · filed 2017-05-03
$19.91M
derived: sum of 2 quarters · filed 2017-05-03
$28.00M
derived: sum of 3 quarters · filed 2017-11-01
$27.17M
derived: sum of 4 quarters · filed 2017-11-01
2016-12-31$15.28M
10-K · filed 2017-03-08
$23.38M
derived: sum of 2 quarters · filed 2017-11-01
$22.54M
derived: sum of 3 quarters · filed 2017-11-01
$18.49M
10-K · filed 2017-03-08
2016-09-30$8.09M
10-Q · filed 2017-11-01
$7.26M
derived: sum of 2 quarters · filed 2017-11-01
$3.20M
10-Q · filed 2017-11-01
$3.20M
10-Q · filed 2016-11-09
$13.35M
derived: sum of 4 quarters · filed 2017-11-01
2016-06-30-$832.00K
10-Q · filed 2017-08-02
-$4.89M
10-Q · filed 2017-08-02
$5.26M
derived: sum of 3 quarters · filed 2017-08-02
$12.50M
derived: sum of 4 quarters · filed 2017-08-02
2016-03-31-$4.06M
10-Q · filed 2017-05-03
$6.09M
derived: sum of 2 quarters · filed 2017-05-03
$13.33M
derived: sum of 3 quarters · filed 2017-05-03
$22.91M
derived: sum of 4 quarters · filed 2017-05-03
2015-12-31$10.15M
10-K · filed 2017-03-08
$17.39M
derived: sum of 2 quarters · filed 2017-03-08
$26.96M
derived: sum of 3 quarters · filed 2017-03-08
$33.37M
10-K · filed 2017-03-08
2015-09-30$7.24M
10-K · filed 2017-03-08
$16.81M
derived: sum of 2 quarters · filed 2017-03-08
$23.22M
10-Q · filed 2016-11-09
$32.50M
derived: sum of 4 quarters · filed 2017-03-08
2015-06-30$9.58M
10-K · filed 2017-03-08
$15.98M
10-Q · filed 2016-08-03
$25.27M
derived: sum of 3 quarters · filed 2017-03-08
$26.75M
derived: sum of 4 quarters · filed 2017-03-08
2015-03-31$6.41M
10-K · filed 2017-03-08
$15.69M
derived: sum of 2 quarters · filed 2017-03-08
$17.17M
derived: sum of 3 quarters · filed 2017-03-08
$18.78M
derived: sum of 4 quarters · filed 2017-03-08
2014-12-31$9.28M
10-K/A · filed 2016-03-16
$10.76M
derived: sum of 2 quarters · filed 2016-03-16
$12.37M
derived: sum of 3 quarters · filed 2016-03-16
$13.13M
10-K · filed 2017-03-08
2014-09-30$1.48M
10-K/A · filed 2016-03-16
$3.09M
derived: sum of 2 quarters · filed 2016-03-16
$3.85M
10-Q · filed 2015-11-04
$6.17M
derived: sum of 4 quarters · filed 2016-03-16
2014-06-30$1.61M
10-K/A · filed 2016-03-16
$2.37M
10-Q · filed 2015-08-05
$4.69M
derived: sum of 3 quarters · filed 2016-03-16
$6.21M
derived: sum of 4 quarters · filed 2016-03-16
2014-03-31$755.00K
10-K/A · filed 2016-03-16
$675.00K
10-Q · filed 2014-05-09
$3.08M
derived: sum of 2 quarters · filed 2016-03-16
$4.60M
derived: sum of 3 quarters · filed 2016-03-16
$10.85M
derived: sum of 4 quarters · filed 2016-03-16
2013-12-31$2.32M
10-K · filed 2015-03-09
$2.15M
10-K · filed 2014-03-12
$3.85M
derived: sum of 2 quarters · filed 2015-03-09
$10.09M
derived: sum of 3 quarters · filed 2015-03-09
$7.01M
10-K/A · filed 2016-03-16
$6.42M
10-K · filed 2014-03-12
2013-09-30$1.52M
10-K · filed 2015-03-09
$1.29M
10-Q · filed 2013-11-08
$7.77M
derived: sum of 2 quarters · filed 2015-03-09
$4.69M
10-Q · filed 2014-11-07
$4.27M
10-Q · filed 2013-11-08
$18.45M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30$6.25M
10-K · filed 2015-03-09
$6.12M
10-Q · filed 2013-08-09
$3.17M
10-Q · filed 2014-08-06
$2.97M
10-Q · filed 2013-08-09
$16.93M
derived: sum of 3 quarters · filed 2015-03-09
$10.98M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31-$3.08M
10-K · filed 2015-03-09
-$3.15M
10-Q · filed 2013-05-10
$10.68M
derived: sum of 2 quarters · filed 2015-03-09
$4.73M
derived: sum of 3 quarters · filed 2015-03-09
$3.91M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31$13.76M
10-Q · filed 2014-11-07
$13.53M
10-K · filed 2013-03-18
$7.81M
derived: sum of 2 quarters · filed 2014-11-07
$6.99M
derived: sum of 3 quarters · filed 2014-11-07
$5.06M
10-K · filed 2015-03-09
$4.84M
10-K · filed 2013-03-18
2012-09-30-$5.95M
10-K · filed 2014-03-12
-$6.77M
derived: sum of 2 quarters · filed 2014-03-12
-$8.70M
10-Q · filed 2013-11-08
-$6.00M
derived: sum of 4 quarters · filed 2014-03-12
2012-06-30-$819.00K
10-K · filed 2014-03-12
-$2.75M
10-Q · filed 2013-08-09
-$47.00K
derived: sum of 3 quarters · filed 2014-03-12
-$4.13M
derived: sum of 4 quarters · filed 2014-03-12
2012-03-31-$1.93M
10-K · filed 2014-03-12
$772.00K
derived: sum of 2 quarters · filed 2014-03-12
-$3.31M
derived: sum of 3 quarters · filed 2014-03-12
-$12.32M
derived: sum of 4 quarters · filed 2014-03-12
2011-12-31$2.70M
10-K · filed 2013-03-18
-$1.38M
derived: sum of 2 quarters · filed 2013-03-18
-$10.40M
derived: sum of 3 quarters · filed 2013-03-18
-$17.31M
10-K · filed 2014-03-12
2011-09-30-$4.08M
10-K · filed 2013-03-18
-$13.10M
derived: sum of 2 quarters · filed 2013-03-18
-$20.01M
10-Q · filed 2012-11-09
-$26.32M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$9.02M
10-K · filed 2013-03-18
-$15.93M
10-Q · filed 2012-08-09
-$22.24M
derived: sum of 3 quarters · filed 2013-03-18
-$20.30M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31-$6.91M
10-K · filed 2013-03-18
-$13.22M
derived: sum of 2 quarters · filed 2013-03-18
-$11.28M
derived: sum of 3 quarters · filed 2013-03-18
-$11.46M
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31-$6.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$4.37M
derived: sum of 2 quarters · filed 2013-03-18
-$4.56M
derived: sum of 3 quarters · filed 2013-03-18
-$2.75M
10-K · filed 2013-03-18
2010-09-30$1.95M
10-Q · filed 2011-11-09
$1.76M
derived: sum of 2 quarters · filed 2011-11-09
$3.56M
10-Q · filed 2011-11-09
2010-06-30-$189.00K
10-Q · filed 2011-08-05
$1.61M
10-Q · filed 2011-08-05
2009-12-31$4.78M
10-K · filed 2012-03-15